Diploma (LON:DPLM – Free Report) had its target price upped by Jefferies Financial Group from GBX 5,200 to GBX 5,700 in a report published on Monday morning, Marketbeat Ratings reports. They currently have a hold rating on the stock.
DPLM has been the topic of a number of other reports. Berenberg Bank upped their price target on shares of Diploma from GBX 6,600 to GBX 7,500 and gave the stock a “buy” rating in a research note on Thursday, March 19th. Deutsche Bank Aktiengesellschaft raised their price objective on shares of Diploma from GBX 6,200 to GBX 6,400 and gave the company a “buy” rating in a research note on Thursday, March 19th. Stifel Nicolaus boosted their price objective on shares of Diploma from GBX 6,200 to GBX 6,800 and gave the stock a “buy” rating in a report on Thursday, March 19th. Shore Capital Group restated a “hold” rating on shares of Diploma in a research report on Wednesday, March 18th. Finally, Peel Hunt reaffirmed a “buy” rating and issued a GBX 6,150 target price on shares of Diploma in a report on Friday, December 19th. Five investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat, Diploma presently has a consensus rating of “Moderate Buy” and an average target price of GBX 6,086.25.
Read Our Latest Analysis on Diploma
Diploma Trading Up 1.6%
Insider Transactions at Diploma
In other news, insider Ian El-Mokadem purchased 500 shares of the business’s stock in a transaction dated Friday, March 20th. The stock was acquired at an average price of GBX 5,820 per share, with a total value of £29,100. Also, insider Johnny Thomson sold 30,000 shares of the business’s stock in a transaction dated Friday, January 16th. The stock was sold at an average price of GBX 5,668, for a total transaction of £1,700,400. Insiders bought 1,352 shares of company stock valued at $7,704,540 in the last 90 days. 1.14% of the stock is currently owned by insiders.
About Diploma
Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.
Further Reading
Receive News & Ratings for Diploma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diploma and related companies with MarketBeat.com's FREE daily email newsletter.
